(Total Views: 470)
Posted On: 08/03/2021 5:12:59 PM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Evil Rabbit #98430
That's just the critical according to clinicaltrials.gov.
Severe trial is: Leronlimab subcutaneously once a week (up to 4 doses) until hospital discharge. The first dose will be of 700 mg, followed by weekly doses of 350 mg.
I guess that could have changed since clinicaltrials.gov updated their site but that was what was originally announced.
Severe trial is: Leronlimab subcutaneously once a week (up to 4 doses) until hospital discharge. The first dose will be of 700 mg, followed by weekly doses of 350 mg.
I guess that could have changed since clinicaltrials.gov updated their site but that was what was originally announced.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)